The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis

The SEPT9 gene methylation assay is the first FDA-approved blood assay for colorectal cancer (CRC) screening. Fecal immunochemical test (FIT), FIT-DNA test and CEA assay are also in vitro diagnostic (IVD) tests used in CRC screening. This meta-analysis aims to review the SEPT9 assay performance and...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Lele, Jia, Jia, Peng, Xiumei, Xiao, Wenhua, Li, Yuemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465203/
https://www.ncbi.nlm.nih.gov/pubmed/28596563
http://dx.doi.org/10.1038/s41598-017-03321-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465203/
https://www.ncbi.nlm.nih.gov/pubmed/28596563
http://dx.doi.org/10.1038/s41598-017-03321-8

Ejemplares similares